Technology News and Research

RSS

Toshiba’s Aquilion ONE CT system improves detection of acute stroke

Kaleida Health's Gates Stroke Center (GSC) at the Gates Vascular Institute in Buffalo, N.Y., a world-class neurological and stroke care center, recently completed the second phase of its study analyzing the patient and fiscal benefits of using Toshiba America Medical System, Inc.'s Aquilion ONE CT system in diagnosing acute stroke.

14 May 2012

European cancer experts report progress with promising new radiosurgical techniques

European cancer experts have reported their progress with promising new radiosurgical techniques for treating cancer and other conditions using new linear accelerator technology from Varian Medical Systems.

14 May 2012

New clinical trial to evaluate effectiveness of ABMT for PTSD

At Ease USA, a Nebraska organization dedicated to providing confidential post-traumatic stress disorder (PTSD) care for military families, has launched a clinical trial of a promising new therapeutic intervention at Creighton University.

14 May 2012

JHSPH wins GCE grant for global health and development research project

The Johns Hopkins Bloomberg School of Public Health announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Alain Labrique, PhD, director of the Johns Hopkins University Global mHealth Initiative, will pursue an innovative global health and development research project, titled "mTIKKA - Harnessing a Mobile - Cloud System to Achieve Universal Vaccination."

14 May 2012

Kidney transplants more frequent among NxStage home hemodialysis patients

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today commented on findings of the Chronic Disease Research Group (CDRG) study showing that patients receiving daily, or more frequent, home hemodialysis with the NxStage System One are more likely to receive a kidney transplant when compared with conventional thrice-weekly dialysis, particularly in patients not on the transplant waitlist at initiation of daily home hemodialysis.

14 May 2012

Towers Watson signs agreement to acquire Extend Health

Towers Watson, a global professional services company, announced today that it has signed an agreement to acquire Extend Health, Inc., which operates the largest private Medicare exchange in the United States.

14 May 2012

Study demonstrates accuracy of AliveCor’s iPhone-based ECG

AliveCor, the developer of a breakthrough mobile electrocardiogram (ECG) recorder, today announced results from a study that demonstrated the accuracy of the company's iPhone-based device, by comparing its Lead I to Lead I from a conventional 12-lead ECG. The study found that the iPhone-based event recorder is an accurate clinical tool for ECG assessment and could prove to be a new tool for allowing immediate recording and analysis of an ECG rhythm.

From AliveCor, Inc. 14 May 2012

New insights into how body's innate immunity is triggered to create effective immune response

Singapore scientists from Bioprocessing Technology Institute (BTI) under the Agency of Science, Technology and Research (A*STAR) have for the first time, identified the molecular 'switch' that directly triggers the body's first line of defence against pathogens, more accurately known as the body's "innate immunity".

11 May 2012

Chromatin compaction required for proper embryonic stem cell differentiation

New research findings show that embryonic stem cells unable to fully compact the DNA inside them cannot complete their primary task: differentiation into specific cell types that give rise to the various types of tissues and structures in the body.

11 May 2012

Bacteria in digestive tracts compete against invading bacteria

From tiny villages in developing nations to suburban kitchens in the United States, dangerous strains of E. coli bacteria sicken millions of people each year - and kill untold numbers of children.

11 May 2012

New discovery platform for antigen-specific monoclonal antibodies

Cell Signaling Technology, Inc. of Danvers, MA is pleased to announce the development of a new discovery platform for antigen-specific monoclonal antibodies.

From Cell Signaling Technology 11 May 2012

Physically active video games can complement traditional exercise

The majority of consumers believe video games should encourage physical activity and that "physically active" video games can complement traditional exercise, according to a new survey released today by UnitedHealth Group.

11 May 2012

Cedars-Sinai’s first patient implanted with SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, said today that Cedars-Sinai Medical Center in Los Angeles has discharged its first patient to be implanted with the SynCardia temporary Total Artificial Heart.

11 May 2012

AACN launches enhanced versions of ECG interpretation, EPCCO

The American Association of Critical-Care Nurses (AACN) has launched enhanced versions of its popular ECG interpretation and pediatric critical care E-Learning courses, conveniently delivering the latest clinical information, tools and resources to nurses and other healthcare professionals.

11 May 2012

CAPE arrests growth of prostate cancer tumors

Could it be that a remedy from thousands of years ago holds the secret to stopping prostate cancer? A newly published study furthers the exploration of caffeic acid phenethyl ester (CAPE) and its potential anticarcinogen and antioxidant properties. The demonstrated ability of CAPE to stop prostate cancer tumors from growing may soon have it earning a spot among other natural remedies for prostate cancer treatment.

11 May 2012

Final results from Alnylam’s ALN-TTR01 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.

11 May 2012

EO2 Concepts added to Marathon Medical's FSS contract

Electrochemical Oxygen Concepts, the developer of a unique and innovative chronic wound treatment device, announced it has been added to Marathon Medical's existing Federal Supply Schedule (FSS) contract, administered by The Department of Veterans Affairs.

11 May 2012